LabMedica

Download Mobile App
Recent News Expo
ADLM 2025
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Point-Of-Care Tool Diagnoses Genetic Mutations within Hours

By LabMedica International staff writers
Posted on 07 Feb 2024

Blood disorders like sickle cell anemia arise from genetic mutations. Typically, newborns are screened for sickle cell disease at birth, with any irregularities reported within 96 hours. However, a follow-up blood test is necessary to confirm the diagnosis, and obtaining these results can take between two to four weeks. Often, seeking genetic analysis through specialized private laboratories can be both time-consuming and expensive. Now, a new tool can detect the presence of genetic mutations within hours instead of weeks.

Researchers at the University of Calgary (Alberta, Canada) have created a system named One-pot DTECT. This innovation is designed for simplicity and ease of use, enabling any laboratory in the world to quickly set up its own kit for same-day genetic mutation analysis at a minimal cost per sample. One-pot DTECT comprises multiple enzymes and distinct DNA fragments that work together to identify and detect genetic signatures. The compact kit includes a small metal box containing 16 vials filled with DNA fragments and an additional two vials of enzymes. This versatile kit is capable of diagnosing a broad spectrum of genetic mutations associated with various disorders, including sickle cell anemia and cystic fibrosis.


Image: The point-of-care kit is designed to diagnose genetic mutations (Photo courtesy of University of Calgary)
Image: The point-of-care kit is designed to diagnose genetic mutations (Photo courtesy of University of Calgary)

Beyond diagnosing patients, the kit is useful for routine laboratory experiments and identifying genetic mutations. The test’s accuracy has been validated, enabling direct analysis from the original blood spot with results available within hours. Discussions are underway with several companies for commercial distribution of the kits. However, the technology is simple and cost-effective, allowing laboratories to easily produce their own kits. The process simply requires specific DNA fragments for sequencing and the necessary enzymes, which are readily available from suppliers.

Related Links:
University of Calgary


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Pipette
Accumax Smart Series

Latest Molecular Diagnostics News

First Blood-Based Test Measures Key Alzheimer's Biomarker in Asymptomatic and Symptomatic Individuals
07 Feb 2024  |   Molecular Diagnostics

Rapid Molecular Diagnostic Device to Detect and Differentiate Ebola and Marburg Virus Species
07 Feb 2024  |   Molecular Diagnostics

New RNA-Based Measure Predicts Mortality Risk and Tracks Aging
07 Feb 2024  |   Molecular Diagnostics



PURITAN MEDICAL